Home » Topics » BioWorld Science, Conferences

BioWorld Science, Conferences
RSS

Peginterferon alfa-2b follow-on biologic is noninferior in phase II/III trial

April 15, 2014

VPM-1002 shows favorable preclinical and early clinical profile for the treatment of bladder cancer

April 15, 2014

Novel sequencing method developed for the GBA gene

April 15, 2014

Novel potent dual kinase EGFR inhibitor synthesized at Innova Pharmaceuticals

April 15, 2014

CellCollector may improve circulating tumor cell collection for breast cancer monitoring

April 15, 2014

Clinical data demonstrate the feasibility of roniciclib in SCLC and ovarian cancer

April 15, 2014

Improved detection of localized prostate cancer with technetium Tc 99m trofolastat

April 14, 2014

GlaxoSmithKline presents promising preclinical data for GSK-2878175

April 14, 2014

Sofosbuvir/GS-5816 gives SVR12 rates > 90% across all HCV genotypes

April 14, 2014

Preliminary data reported for clinical study of UX-003 in mucopolysaccharidosis type VII

April 14, 2014

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 24, 2026.
A free gene therapy? Regeneron’s Otarmeni approved for hearing loss
BioWorld
Children and adults with a type of congenital hearing loss now have a free treatment option, with the U.S. FDA’s accelerated approval of Regeneron Pharmaceuticals...
Detecting the invisible: minimal residual disease at AACR 2026
BioWorld Science
Minimal residual disease (MRD) has become a central concept in modern oncology, reshaping how clinicians evaluate response, relapse risk and treatment precision....
AACR 2026: The age of agentic AI in oncology
BioWorld Science
New Approach Methodologies (NAMs) for drug development are transforming biomedical research by replacing or complementing animal models. More than 90% of...
In the clinic for April 21, 2026
BioWorld
Clinical updates for biopharma and med tech, including data readouts and publications: Abbott, Agenus, Astrazeneca, Briacell, Clearmind, Greenwich, Intodna,...